You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

M89PF

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

M89PF in Rosacea Associated With Erythema and Sensitive Skin

Completed
  • Rosacea
    • Milan, Italy
      ISPE
    Sep 28, 2022

    NSCLC Trial in Heidelberg (89Zirconium-M7824, M7824)

    Terminated
    • Non-Small Cell Lung Cancer
    • Heidelberg, Victoria, Australia
      Austin Health
    Jan 13, 2023

    Metastatic Malignant Solid Tumor Trial in Duarte (procedure, radiation, drug)

    Recruiting
    • Metastatic Malignant Solid Neoplasm
    • Lymphoma
    • Positron Emission Tomography
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Nov 18, 2022

    Melanoma, Renal Cell Carcinoma Trial in Hull (Zirconium 89Zr crefmirlimab berdoxam)

    Recruiting
    • Melanoma
    • Renal Cell Carcinoma
    • Zirconium 89Zr crefmirlimab berdoxam
    • Hull, United Kingdom
      Castle Hill Hospital
    Feb 15, 2023

    Melanoma (Skin) Trial in Philadelphia (89Zr-Df-IAB22M2C PET/CT)

    Enrolling by invitation
    • Melanoma (Skin)
    • 89Zr-Df-IAB22M2C PET/CT
    • Philadelphia, Pennsylvania
      Perleman Center for Advanced Medicine
    May 31, 2022

    CD8+ T-cell PET/CT Imaging in COVID-19 Patients

    Recruiting
    • Lymphopenia Due to COVID-19
    • +2 more
    • [89Zr]Df-IAB22M2C PET/CT scan
    • Nijmegen, Gelderland, Netherlands
      Radboud university medical center
    Jun 2, 2022

    Alzheimer's Disease Trial in Worldwide (PF-04360365 0.1 mg/kg, PF-04360365 0.5 mg/kg, PF-04360365 1 mg/kg)

    Completed
    Has Results
    • Alzheimer's Disease
    • PF-04360365 0.1 mg/kg
    • +5 more
    • Peoria, Arizona
    • +41 more
    Oct 11, 2022

    Positron-Emission Tomography, Metastatic Solid Tumors Trial in United States (8?Zr-Df-IAB22M2C)

    Completed
    • Positron-Emission Tomography
    • Metastatic Solid Tumors
    • Birmingham, Alabama
    • +14 more
    Nov 15, 2022

    Blepharoptosis, Synkinesis, Hyperkinesis Trial in Hershey (Oxymetazoline 0.1% (Pf) Oph Soln Ud, Preservative free lubricating

    Not yet recruiting
    • Blepharoptosis
    • +3 more
    • Oxymetazoline 0.1% (Pf) Oph Soln Ud
    • Preservative free lubricating drops
    • Hershey, Pennsylvania
      M.S. Hershey Medical Center
    Jul 6, 2023

    Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Houston

    Active, not recruiting
    • Metastatic Colorectal Carcinoma
    • +4 more
    • Cetuximab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 4, 2022

    Urinary Bladder Tumors, Colorectal Cancer, NSCLC Trial in Worldwide (AZD8853, Zirconium-89 crefmirlimab berdoxam)

    Recruiting
    • Urinary Bladder Neoplasms
    • +2 more
    • AZD8853
    • Zirconium-89 crefmirlimab berdoxam
    • New Haven, Connecticut
    • +14 more
    Aug 8, 2022

    COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

    Active, not recruiting
    • COL6A3 Positive
    • +3 more
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Rosacea, Sensitive Skin Trial in Milano (Mineral 89 Probiotic Fractions)

    Active, not recruiting
    • Rosacea
    • Sensitive Skin
    • Mineral 89 Probiotic Fractions
    • Milano, MI, Italy
      ISPE srl
    May 18, 2021

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Axitinib,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 16, 2021

    Metastatic Melanoma Trial in Duarte, Portland, Philadelphia (Bempegaldesleukin (NKTR-214), Nivolumab, 8?Zr-Df-IAB22M2C)

    Withdrawn
    • Metastatic Melanoma
    • Bempegaldesleukin (NKTR-214)
    • +2 more
    • Duarte, California
    • +2 more
    Jun 28, 2021

    Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody

    Active, not recruiting
    • Recurrent Acute Myeloid Leukemia
    • Refractory Acute Myeloid Leukemia
    • Anti-OX40 Agonist Monoclonal Antibody PF-04518600
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 25, 2022

    Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density

    Active, not recruiting
    • Atherosclerotic Cardiovascular Disease
    • +2 more
    • Sale, Cheshire, United Kingdom
    • +16 more
    Jan 20, 2023

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Worldwide (Glasdegib, Azacitidine)

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Salzburg, Austria
    • +17 more
    Dec 14, 2022

    Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

    Active, not recruiting
    • Prolymphocytic Leukemia
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 7, 2022

    Tumor Metastasis Trial in Worldwide (PF-07265807, Sasanlimab, Axitinib)

    Recruiting
    • Neoplasm Metastasis
    • Fayetteville, Arkansas
    • +33 more
    Aug 20, 2022

    Active Non-segmental Vitiligo Trial in Worldwide (PF-06651600, , PF06700841)

    Completed
    Has Results
    • Active Non-segmental Vitiligo
    • Huntington Beach, California
    • +91 more
    Mar 1, 2022

    Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Houston (Rituximab, Zanubrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 9, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +2 more
    • Los Angeles, California
    • +4 more
    Jul 19, 2022

    Atopic Dermatitis, Plaque Psoriasis Trial (PF-07038124 ointment 0.01%, Vehicle ointment, PF-07038124 ointment 0.03%)

    Recruiting
    • Atopic Dermatitis
    • Plaque Psoriasis
    • PF-07038124 ointment 0.01%
    • +3 more
    • Encinitas, California
    • +31 more
    Jan 23, 2023

    Primary Immune Thrombocytopenia Trial in Worldwide (PF-06835375)

    Suspended
    • Primary Immune Thrombocytopenia
    • PF-06835375
    • Jacksonville, Florida
    • +27 more
    Jan 25, 2023